Trillium Therapeutics Net Tangible Assets

Trillium Therapeutics (TRIL) currently reports a net tangible assets of $240M as of September 2021. That compares with $180M in the prior-year period — up 31.9% year over year. Use the charts on this page to explore Trillium Therapeutics's net tangible assets history and peer comparisons.

Trillium Therapeutics's net tangible assets increased from $180M to $240M — a 31.9% year-over-year increase (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Trillium Therapeutics reported $240M in net tangible assets as of September 2021. That compares with $180M in the prior-year period — up 31.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $240M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Trillium Therapeutics, and consider following TRIL for alerts when major investors trade the stock.

Trillium Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $240M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TRIL with unrelated industries.